It is not clear whether or not these pathways contribute to CAD associated with the LRP6 mutations; and (3) although Wang et al. identified MEF2A as a causal gene for CAD, we did not find any mutation in this gene during our first screening. This evidence concerns the gene LRP6 and coronary artery disorder.